Pharmaceutical

Cue Biopharma downsizes to focus on autoimmune pipeline

The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.

Jul 28, 2024 - 04:00
Cue Biopharma downsizes to focus on autoimmune pipeline
The company has fired 25% of its staff and plans to look for partnerships to further its oncology candidates.
Read the original article

Tags:

Previous Article

Inside the efforts to rescue a rare disease gene therapy 

Next Article

Roche records 4% decline in H1 2024 net income

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Biden administration proposes yearly audit for costliest Medicaid drugs; few at high risk of HIV take prevention pills

STAT+: Pharmalittle: Biden administration proposes year...

May 25, 2023

argenx’s VYVDURA gains approval in Japan for gMG treatment

argenx’s VYVDURA gains approval in Japan for gMG treatment

Jan 19, 2024

STAT+: The Ozempic panic: Why a market frenzy over new weight loss drugs defies logic

STAT+: The Ozempic panic: Why a market frenzy over new ...

Oct 18, 2023